Clinical factors associated with improved survival following allogeneic HSCT after CD19 CAR therapy in adult patients with relapsed B-ALL Meeting Abstract


Authors: Park, J. H.; Flynn, J.; Gonen, M.; Bernal, Y.; Diamonte, C.; Halton, E.; Wang, X.; Riviere, I.; Sadelain, M.; Brentjens, R. J.
Abstract Title: Clinical factors associated with improved survival following allogeneic HSCT after CD19 CAR therapy in adult patients with relapsed B-ALL
Meeting Title: 61st Annual Meeting and Exposition of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 134
Issue: Suppl. 1
Meeting Dates: 2019 Dec 7-10
Meeting Location: Orlando, FL
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2019-11-13
Language: English
ACCESSION: WOS:000577160401163
DOI: 10.1182/blood-2019-129343
PROVIDER: wos
Notes: Meeting Abstract: 1348 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Renier J Brentjens
    286 Brentjens
  2. Mithat Gonen
    1028 Gonen
  3. Jae Hong Park
    356 Park
  4. Elizabeth F Halton
    53 Halton
  5. Michel W J Sadelain
    583 Sadelain
  6. Isabelle C Riviere
    240 Riviere
  7. Xiuyan Wang
    118 Wang
  8. Yvette J Bernal
    32 Bernal
  9. Jessica Flynn
    182 Flynn